User profiles for "author:C. Denkert"
 | Carsten DenkertProfessor of Pathology, Philipps-University Marburg, Germany Verified email at uni-marburg.de Cited by 63715 |
[HTML][HTML] The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
(TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …
[HTML][HTML] Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast …
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno …
…, K Emancipator, JW Juco, C Denkert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …
implications of this response are increasingly recognized, and as immunotherapies are …
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Validating prognostic or predictive candidate genes in appropriately powered breast cancer
cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots …
cohorts are of utmost interest. Our aim was to develop an online tool to draw survival plots …
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer
Purpose Preclinical data suggest a contribution of the immune system to chemotherapy
response. In this study, we investigated the prespecified hypothesis that the presence of a …
response. In this study, we investigated the prespecified hypothesis that the presence of a …
[HTML][HTML] Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the …
Background We have previously shown the prognostic importance of tumor-infiltrating
lymphocytes (TILs) in newly diagnosed triple-negative breast cancer (TNBC) using tumor …
lymphocytes (TILs) in newly diagnosed triple-negative breast cancer (TNBC) using tumor …
[PDF][PDF] Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
…, M Kaufmann, GE Konecny, C Denkert… - J Clin …, 2012 - aula.campuspanamericana.com
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant
Chemotherapy in Various Intrinsic Breast Ca Page 1 Definition and Impact of Pathologic Complete …
Chemotherapy in Various Intrinsic Breast Ca Page 1 Definition and Impact of Pathologic Complete …
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
C Denkert, G von Minckwitz, S Darb-Esfahani… - The lancet …, 2018 - thelancet.com
Summary Background Tumour-infiltrating lymphocytes (TILs) are predictive for response to
neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) and HER2-positive …
neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) and HER2-positive …
[HTML][HTML] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of …
ABSTRACT The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna,
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …
[HTML][HTML] Event-free survival with pembrolizumab in early triple-negative breast cancer
Background The addition of pembrolizumab to neoadjuvant chemotherapy led to a
significantly higher percentage of patients with early triple-negative breast cancer having a …
significantly higher percentage of patients with early triple-negative breast cancer having a …